Literature DB >> 6688129

The etiology of prostate cancer: what does the epidemiology suggest?

R K Ross, A Paganini-Hill, B E Henderson.   

Abstract

The two most important demographic characteristics of prostate cancer in Los Angeles are the high rates among blacks, which are two times those among whites and four times those among Asians, and the rapid increase in rates with age after age 40. Despite the high rates among blacks, a birth cohort analysis indicates that mortality rates among black men born after 1900 have decreased. In this report, epidemiologic and experimental evidence supporting each of three etiologic hypotheses--industrial exposure to cadmium, sexual transmission by an infectious agent, and endocrine factors--are reviewed. Evidence from descriptive data in Los Angeles suggests that only a small portion of cases might be attributable to industrial exposures. In a cohort study of Catholic priests, we found no deficit of prostate cancer mortality, strong evidence against sexual transmission of the disease. Experimental evidence and a limited amount of human data support an endocrine hypothesis. Preliminary results of a case-control study of prostate cancer are presented, but these results are unable to distinguish among these hypotheses further. This study finds a substantial protective effect of vasectomy, an event that is accompanied by reduced prostatic function and size, but this result is thus far statistically insignificant.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6688129     DOI: 10.1002/pros.2990040403

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  14 in total

1.  The Association Between Vasectomy and Prostate Cancer: A Systematic Review and Meta-analysis.

Authors:  Bimal Bhindi; Christopher J D Wallis; Madhur Nayan; Ann M Farrell; Landon W Trost; Robert J Hamilton; Girish S Kulkarni; Antonio Finelli; Neil E Fleshner; Stephen A Boorjian; R Jeffrey Karnes
Journal:  JAMA Intern Med       Date:  2017-09-01       Impact factor: 21.873

Review 2.  Prostate cancer: 3. Individual risk factors.

Authors:  R P Gallagher; N Fleshner
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

Review 3.  Male circumcision and prostate cancer: A geographical analysis, meta-analysis, and cost analysis.

Authors:  Robert S Van Howe
Journal:  Can Urol Assoc J       Date:  2020-07       Impact factor: 1.862

Review 4.  Androgen-receptor gene structure and function in prostate cancer.

Authors:  J M Hakimi; R H Rondinelli; M P Schoenberg; E R Barrack
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

5.  Estrogen receptor alpha gene polymorphisms and risk of prostate cancer: a meta-analysis involving 18 studies.

Authors:  Zhenwei Gu; Gang Wang; Weiguo Chen
Journal:  Tumour Biol       Date:  2014-03-01

6.  Risk of testicular cancer after vasectomy: cohort study of over 73,000 men.

Authors:  H Møller; L B Knudsen; E Lynge
Journal:  BMJ       Date:  1994-07-30

Review 7.  Inflammation and prostate cancer: a focus on infections.

Authors:  Siobhan Sutcliffe; Elizabeth A Platz
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

8.  Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations.

Authors:  K V Honn; A Aref; Y Q Chen; M L Cher; J D Crissman; J D Forman; X Gao; D Grignon; M Hussain; A T Porter; J E Pontes; I Powell; B Redman; W Sakr; R Severson; D G Tang; D P Wood
Journal:  Pathol Oncol Res       Date:  1996-03       Impact factor: 3.201

9.  Vasectomy and the risk of prostate cancer in a cohort of multiphasic health-checkup examinees: second report.

Authors:  S Sidney; C P Quesenberry; M C Sadler; H A Guess; E G Lydick; E V Cattolica
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

10.  The Strong Protective Effect of Circumcision against Cancer of the Penis.

Authors:  Brian J Morris; Ronald H Gray; Xavier Castellsague; F Xavier Bosch; Daniel T Halperin; Jake H Waskett; Catherine A Hankins
Journal:  Adv Urol       Date:  2011-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.